MTMarilena Taggi

Marilena Taggi

*This is an algorithmically generated author record based on publicly available information.

Marilena Taggi has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Germinal vesicle oocytes’ rescue: a worthless treatment or a patient-centred approach? Eight years of clinical experience in poor prognosis patients

    by Danilo Cimadomo, Laura Escrich, Lucía Alegre, Noelia Grau, Arancha Galán, Cristina Rodríguez Varela, Marilena Taggi, Sara Pasku, Laura Rienzi, Ernesto Bosch, et al.

    STUDY QUESTION: Does germinal vesicle (GV) rescue by IVM provide a meaningful clinical benefit in patients with unexpectedly low mature oocyte yield, and which patient profiles are most likely to benefit? SUMMARY ANSWER: Especially in patients with more GV oocytes obtained, GV rescue increased the number of mature oocytes, zygotes, blastocysts, and euploid embryos per cycle, reduced transfer cancellation, and contributed to a 20% relative increase in cumulative live birth rate. WHAT IS KNOWN ALREADY: Immature oocytes retrieved during controlled ovarian stimulation are traditionally discarded due to their reduced developmental competence. Previous studies suggest that GV rescue may increase usable oocytes, but its clinical value, especially within a Pre-implantation Genetic Testing for Aneuploidies (PGT-A) framework, remains unclear. STUDY DESIGN, SIZE, DURATION: This retrospective clinical study analysed 8 years of GV rescue experience in a single centre (January 2017–December 2024), including 47 women (<39 years) undergoing ICSI with PGT-A who displayed suboptimal mature oocyte recovery (Metaphase II oocytes (MII) ≤6, maturity rate <80% relative to ≥14 mm follicles at ovulation trigger, and ≥4 GV oocytes). A sub-analysis of available time-lapse videos of rescued GV oocytes and sibling control MII oocytes was conducted to outline morphometric and morphodynamic determinants of rescue and blastulation. PARTICIPANTS/MATERIALS, SETTING, METHODS: All retrieved MII oocytes underwent ICSI, whereas GV oocytes were cultured in time-lapse systems for additional 24 h; those rescued (rMII) were inseminated. Outcomes included fertilization, blastulation, morphological quality, euploidy rates, and clinical outcomes after vitrified-warmed euploid blastocyst transfer. Patients’ benefit was defined as obtaining ≥1 euploid blastocyst from rMII. Morphometric features (relevant areas, diameters, perimeters) and morphodynamic parameters (timing of GV breakdown [GVBD], metaphase-I duration and first polar body (PB1) extrusion, second polar body (PB2) extrusion, pronuclei appearance, juxtaposition and fading, and cleavage) were annotated. MAIN RESULTS AND THE ROLE OF CHANCE: Among 266 GV oocytes, 53.7% matured to MII, increasing the available MII yield per patient by 75%. Fertilization rates were comparable between MII and rMII, while blastulation was significantly lower for rMII. Nevertheless, rMII-derived blastocysts showed similar morphology and euploidy to controls and contributed ≥1 additional euploid embryo in 11 patients. These patients exhibited higher total cumulus–oocyte complexes, GV count, and superior rMII fertilization and blastulation, although the demographics and basal parameters as well as the sibling control MII competence were comparable. GV rescue contributed to an 8% relative increase in the number of patients with euploid blastocysts and to a 20% relative increase in the number of patients with a live birth. Successfully rescued GV oocytes were substantially larger and underwent faster GVBD. rMII oocytes were significantly smaller than sibling control MII oocytes. Among the former, earlier pronuclear juxtaposition and shorter cleavage timings were associated with successful blastocyst development. LIMITATIONS, REASONS FOR CAUTION: The design is retrospective at a private IVF centre. The sample size is small, although this is the consequence of purposely strict inclusion criteria. Findings apply to patients with unexpectedly low MII yield undergoing PGT-A cycles in experienced laboratories. WIDER IMPLICATIONS OF THE FINDINGS: GV rescue represents a patient-centred strategy that can increase cumulative IVF success in cycles with limited mature oocyte yield. Further refining of patient selection criteria and standardizing this approach may enhance its clinical utility in future appraisals. The definition of artificial intelligence-powered pipelines to extract relevant morphometric/morphodynamic features to inform future predictive tools along with improvements in rescue protocols represent important upcoming innovations in this area of research. STUDY FUNDING: The study was partially supported by the ESHRE Research Grant 2024. DISCLOSURES: The authors declare no conflict of interest related with the content of this manuscript. TRIAL REGISTRATION NUMBER: Not applicable.

  • Open Access

    Comparing endometrial preparation protocols and clinical outcomes: lessons learned from 3507 vitrified-warmed euploid transfers

    by Erika Pittana, Alessandro Ruffa, Giosuè Giordano Incognito, Federica Battista, Federica Innocenti, Marilena Taggi, Michele Morelli, Maurizio Guido, Carla Ettore, Giuseppe Rizzo, et al.

    Purpose: To evaluate whether artificial endometrial preparation using hormone replacement therapy (HRT) influences clinical and neonatal outcomes compared with modified natural cycles (mNC) in single euploid vitrified–warmed blastocyst transfers. Methods: This retrospective cohort study analyzed single euploid vitrified–warmed blastocyst transfers performed at a single IVF center over an 11-year period. Endometrial preparation was conducted either through HRT or mNC. Clinical and neonatal outcomes were compared between groups. Statistical analyses included multivariable logistic regression models, adjusted for relevant confounders, with generalized estimating equations to account for repeated embryo transfers (ETs) within patients. Results: A total of 3507 ETs were conducted in 2257 patients. Mean age was 37.5 ± 3.2 years at oocyte pick-up and 37.8 ± 3.3 years at ET. HRT was associated with a higher miscarriage rate ( N = 167/1034, 16.2% vs N = 70/700, 10%; OR 1.72, 95% CI 1.27–2.33) and a lower live birth rate ( N = 867/2129, 40.7% vs N = 630/1378, 45.7%; OR 0.83, 95% CI 0.72–0.96) than mNC. Additionally, HRT was associated with a higher prevalence of large for gestational age newborns. Conclusions: mNC endometrial preparation may show some clinical benefit compared to HRT. The latter remains necessary in specific cases, such as hypothalamic amenorrhea (excluded in this study), but mNC protocols should be preferred whenever possible. Randomized controlled trials in Preimplantation Genetic Testing for Aneuploidy (PGT-A) cycles are essential to confirm these findings.

  • The emerging role of the oocyte cortical domain in maturation, fertilization, and development

    by Giovanni Coticchio, Valentina Casciani, Laura Rienzi, Danilo Cimadomo, Chiara Cosseddu, Marilena Taggi, Sergio Ledda, Daniela Bebbere

    The cell cortex, a cytoskeletal network with regulatory signalling pathways, is localized beneath the cell membrane: it is especially prominent in mammalian oocytes. As in other cells, the cortex ensures appropriate shape and robustness of oocytes. It is also involved in other key and more specific functions. The cortex is part of the interface between the germinal and somatic cell compartments; as such, it participates in the delicate bi-directional interaction by which oocytes regulate cumulus cell function and in return, oocytes receive nutrients and regulative factors from cumulus cells. During oocyte maturation, fertilization, and early development, the cortex undergoes major structural and functional modifications. Such changes are needed to support crucial processes, including meiotic spindle localization, polar body extrusion, chromosome segregation, and pronuclear formation. Cortex dysregulation may be also implicated in blastomere fragmentation during early embryo development. Mechanical properties of the cortex are associated with oocyte quality and developmental competence; with appropriate technology, such properties could be harnessed to develop new approaches to non-invasive oocyte assessment in human IVF.


  • Embryos not showing pronuclei by single static observation arise from atypical pronuclear dynamics or rare unfertilized oocytes with abortive cleavage behaviour

    by Giovanni Coticchio, Marilena Taggi, Francesca Asturi, Alfredo Stati, Maria Bordignon, Federica Innocenti, Gaia Saturno, Alberto Vaiarelli, Laura Rienzi, Danilo Cimadomo

    STUDY QUESTION: Is the non-pronuclear (0PN) fertilization pattern, as assessed by single static observation during the 16- to 18-h post-insemination (hpi) interval, compatible with embryo developmental competence? SUMMARY ANSWER: A few zygotes show pronuclei (PN) solely outside the static fertilization assessment time interval and can develop to blastocyst stage, while rare cases of cleavage without pronuclear formation always result in early developmental arrest or degeneration. WHAT IS KNOWN ALREADY: Recently, the use of atypically pronucleated zygotes—showing no, one, or three PN (0PN, 1PN, and 3PN), or other less frequent patterns—has been increasingly proposed as a measure to maximize the number of embryos available for treatment and the cumulative clinical outcome per cycle. The use of such zygotes poses important clinical and ethical concerns; it also raises scientific questions, such as the hypothesis that the 0PN pattern can be compatible with pre- and post-implantation development in the absence of actual formation of PN. Allowing detailed observation of embryo morphokinetics, time-lapse technology (TLT) can be decisive in resolving such questions. STUDY DESIGN, SIZE, DURATION: Retrospective observational study (2013–2020) including 6035 oocytes inseminated by ICSI and cultured in a time-lapse imaging incubator system. Zygotes (N = 4479), classified by PN-type, were divided into sub-groups based on timings of PN appearance (tPNa: 16hpi) and PN fading (tPNf: 20hpi). Their development was monitored until blastocyst stage. The remaining 1556 injected oocytes were either degenerated (N = 801) or did not show PN (true-0PN; N = 755). Among the latter, 186 showed ≥1 cleavage(s) and then degenerated. Their videos were analysed to assess events preceding developmental arrest. PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovarian stimulation with GnRH-antagonist and hCG/agonist trigger was performed, with all patients undergoing ICSI and blastocyst culture. The study endpoints were the blastulation rates across different PN-appearance and -fading thresholds, as well as a thorough description of the events during cell division(s) in 0PN embryos that experienced early arrest. Regression analyses were conducted, adjusting for confounders such as maternal age, male factor, and PN-type, with associations confirmed using generalized estimating equations. MAIN RESULTS AND ROLE OF CHANCE: Zygotes showing two PN (2PN, N = 4479) monitored by TLT were distributed in sub-groups based on tPNf (20 hpi, N = 4115). In a few cases (N = 85), PN formation occurred after 16 hpi, up until 31 hpi. Single static observation during the 16- to 18-hpi conventional interval would have missed the zygotes undergoing very early PNf and at least part of those undergoing late PNa. Comparison between the above sub-groups showed that pronuclear fading occurring at 18–20 hpi was associated with the highest blastocyst formation rate (36.4%, 47.7%, 65.4%, and 53.3%, for the diverse tPNf, respectively; P < 0.001). Late tPNa (>16 hpi) was accompanied by reduced blastocyst formation rate (54.5% vs 29.4%; P < 0.001). tPNf occurring at 18–20 hpi was also associated with a higher blastocyst euploidy rate. Of 755 true-0PN oocytes, 186 (24.6%) underwent ≥1 cleavage(s). However, all of them arrested before compaction, often displaying irregular cleavage(s) (including direct, reverse, and chaotic), vacuolization, and/or extensive fragmentation. LIMITATIONS, REASONS FOR CAUTION: The study data are derived from a single, although large, dataset. Therefore, they require independent confirmation. In addition, assessment of fertilization morphokinetics can only be applied to ICSI insemination, leaving fertilization morphokinetics achieved by standard IVF unexplored. WIDER IMPLICATIONS OF THE FINDINGS: TLT confirms the limitations of single static observation, which fails to detect a significant proportion of zygotes, especially if executed relatively late. This has implications for fertilization assessment, prediction of blastulation, and utilization of atypically pronucleated zygotes. Moreover, TLT demystifies the belief that blastocyst development may occur in the absence of pronuclear formation. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: None.


  • Optimizing IVF lab workflows through data-driven insights: associations between lab management, procedural timings, and workload with blastulation rates

    by Federica Innocenti, Greta Chiara Cermisoni, Marilena Taggi, Valentina Casciani, Daria Maria Soscia, Lisa Dovere, Marta Stoppa, Laura Albricci, Alberto Vaiarelli, Giovanni Coticchio, et al.

    STUDY QUESTION: Do IVF laboratory workflows influence the mean blastulation rate per cohort of inseminated metaphase II oocytes (m-BR)? SUMMARY ANSWER: Neither the total number of procedures nor the workload per operator affected m-BR; instead, each additional hour in the interval from ovulation trigger to oocyte denudation (range 36–44 h) was associated with a measurable decline, especially beyond the 40-h threshold. WHAT IS KNOWN ALREADY: Control of laboratory conditions and standardized protocols are essential for optimizing m-BR in IVF. While advancements in technology and culture systems have improved ART outcomes, the effect of laboratory managerial decisions and procedural timing on embryological outcomes remains unclear. Previous studies have suggested that factors, such as prolonged oocyte handling, suboptimal culture conditions, and organizational inefficiencies, may affect in vitro embryo development, but available data are still limited. STUDY DESIGN, SIZE, DURATION: This retrospective study analyzed 7986 ICSI cycles performed between 2015 and 2022 at a private IVF center. Data were automatically registered and then retrospectively extracted from an Electronic Witnessing System to evaluate workload distribution and procedural timings. The study aimed to assess whether variations in laboratory managerial decisions influence the m-BR. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included all patients undergoing ICSI with fresh own oocytes. Metrics under investigation included the number of daily procedures overall and per operator and procedural timings, such as the interval between ovulation trigger and oocyte denudation. Results were adjusted for confounders, including maternal age, male factor infertility, and culture conditions. Multivariate linear regression and generalized estimating equations were used to assess associations with m-BR, accounting for repeated measures in couples undergoing multiple retrievals. MAIN RESULTS AND THE ROLE OF CHANCE: The overall m-BR was 35.7 ± 28.1% with 79% of the cycles resulting in at least one blastocyst obtained. No significant association was found between daily workload and m-BR, indicating that the number of daily procedures did not impact laboratory performance. After adjusting for confounders (maternal age, sperm factor, incubation conditions, and culture medium type), only the timing between ovulation trigger and oocyte denudation emerged as critical. A consistent and significant decline in m-BR was observed with each additional hour of delay between 36- and 44-h post-trigger (unstandardized coefficient B: −1.6%, 95% CI: −2.1 to –1.1%). The time between oocyte retrieval and denudation (range: 2–6 h) showed a significant association with a lower chance to obtain at least one blastocyst in each ICSI cycle (adjusted OR: 0.91, 95% CI: 0.86–0.96, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: This was a retrospective single-center study. While the findings are robust and relevant for high-volume IVF laboratories, they may not be directly generalizable to smaller clinics with different workflows or lower caseloads. Additionally, only ICSI cycles were included; further studies are needed to confirm the findings for conventional IVF in different settings and patient populations. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that even large workloads can be managed without compromising IVF performance, provided that lab schedules and personnel are carefully coordinated to meet ideal timing requirements. In the future, artificial intelligence models may support these lab management activities by predicting workloads and helping maintain timely schedules. STUDY FUNDING/COMPETING INTEREST(S): No funding. The authors declare no conflict of interest related with the content of this study. TRIAL REGISTRATION NUMBER: N/A.


  • Open Access

    Quantitative Standardized Expansion Assay: An Artificial Intelligence-Powered Morphometric Description of Blastocyst Expansion and Zona Thinning Dynamics

    by Danilo Cimadomo, Samuele Trio, Tamara Canosi, Federica Innocenti, Gaia Saturno, Marilena Taggi, Daria Maria Soscia, Laura Albricci, Ben Kantor, Michael Dvorkin, et al.

    Artificial intelligence applied to time-lapse microscopy may revolutionize embryo selection in IVF by automating data collection and standardizing the assessments. In this context, blastocyst expansion dynamics, although being associated with reproductive fitness, have been poorly studied. This retrospective study (N = 2184 blastocysts from 786 cycles) exploited both technologies to picture the association between embryo and inner-cell-mass (ICM) area in µm2, the ICM/Trophectoderm ratio, and the zona pellucida thickness in µm (zp-T) at sequential blastocyst expansion stages, with (i) euploidy and (ii) live-birth per transfer (N = 548 transfers). A quantitative-standardized-expansion-assay (qSEA) was also set-up; a novel approach involving automatic annotations of all expansion metrics every 30 min across 5 h following blastulation. Multivariate regressions and ROC curve analyses were conducted. Aneuploid blastocysts were slower, expanded less and showed thicker zp. The qSEA outlined faster and more consistent zp thinning processes among euploid blastocysts, being more or as effective as the embryologists in ranking euploid embryo as top-quality of their cohorts in 69% of the cases. The qSEA also outlined faster and more consistent blastocyst expansion and zp thinning dynamics among euploid implanted versus not implanted blastocysts, disagreeing with embryologists’ priority choice in about 50% of the cases. In conclusion, qSEA is a promising objective, quantitative, and user-friendly strategy to predict embryo competence that now deserves prospective validations.


  • Open Access

    Embryo multinucleation: detection, possible origins, and implications for treatment

    by Giovanni Coticchio, Cristina Lagalla, Marilena Taggi, Danilo Cimadomo, Laura Rienzi

    Cell cycle regulation is crucial to assure expansion of a cell population, while preserving genome integrity. This notion is especially relevant to fertilization and early embryo development, a time when the cell cycle transforms from meiotic into mitotic cycles. Zygote-to-embryo transition is acutely error-prone, causing major developmental perturbations, including cleavage delays, tri- and multi-chotomous cleavages, and cell fragmentation. Another such alteration is bi- and multinucleation, consisting of the simultaneous formation of two or more nuclei at interphase. Indeed, multinucleation affects a large proportion of early human embryos, typically at the two-cell stage. Mechanistically, several factors, including spindle dysfunction, failed cleavage, and cell fusion, may generate this cell anomaly. In assisted reproduction treatment, multinucleation is associated with reduced developmental rates and lower implantation rates in Days 2–3 embryo transfers. However, many multinucleated embryos can develop to the blastocyst stage. In blastocyst transfers, the current evidence does not suggest a major impact of a previous history of multinucleation on the odds of euploidy or successful treatment outcomes. Human embryo multinucleation remains a not-fully-understood but developmentally relevant and intriguing phenomenon which requires further research of its generative mechanisms and clinical implications.